Mariner, LLC Compugen LTD Transaction History
Mariner, LLC
- $55.8 Billion
- Q3 2024
A detailed history of Mariner, LLC transactions in Compugen LTD stock. As of the latest transaction made, Mariner, LLC holds 11,771 shares of CGEN stock, worth $27,191. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,771
Previous 12,012
2.01%
Holding current value
$27,191
Previous $20,000
5.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CGEN
# of Institutions
77Shares Held
13.1MCall Options Held
79.2KPut Options Held
12.7K-
Silverarc Capital Management, LLC1.5MShares$3.47 Million0.68% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$2.97 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.2MShares$2.78 Million1.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.09MShares$2.52 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$2.36 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $200M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...